Following revelations that Superior HealthPlan's former CEO admitted to hiring private investigators to spy on patients, doctors, and state lawmakers, Centene Corporation issued a statement distancing itself from the practice. Despite this condemnation, questions remain over whether company leadership was aware of the surveillance tactics, raising concerns about ethical oversight and accountability.

Centene Corporation, as the corporate parent of Health Net Federal Services, agreed to pay over $11 million to settle allegations that it falsely certified cybersecurity compliance under its federal contract with the DoD. The settlement addresses claims that, between 2015 and 2018, the company misrepresented its adherence to critical cybersecurity controls, thereby undermining safeguards for sensitive government information.

Centene Corporation, through its subsidiary Health Net Federal Services, settled for over $11M to resolve allegations of falsely certifying cybersecurity compliance on a DoD contract, which covered failures between 2015 and 2018. This settlement highlights serious lapses in upholding cybersecurity standards in handling sensitive government data.

Centene Corporation and its subsidiary, Health Net Federal Services Inc., have settled allegations of non‐compliance with federal cybersecurity requirements by paying $11,253,400. The settlement, announced on February 18, 2025, addresses claims that between 2015 and 2018 the company falsely certified compliance under a DoD contract for administering TRICARE, raising serious concerns about the integrity of its business practices and technology safeguards.

Confidential HR documents have revealed that Centene Corporation is planning a significant round of layoffs scheduled to begin between October 2 and October 5, with the final termination on December 8, 2023. The documents include scripted notification meetings for affected employees and indicate broader trends of aggressive cost-cutting measures and harsh labor practices.

Centene Corporation announced it will cut 2,000 positions next week as part of a restructuring effort aimed at right-sizing its cost structure. The move, affecting roughly 3% of its workforce, follows challenges related to post‐pandemic adjustments and regulatory changes in Medicaid. Although the company is providing severance packages and outplacement services to affected employees, the mass layoff raises concerns about the erosion of worker job security and broader labor rights.

Centene Corporation has agreed to pay over $215 million to California to settle allegations of overbilling for pharmacy services in its Medi-Cal program. Investigations revealed that Centene’s subsidiaries inflated drug costs and fees, adversely affecting vulnerable, low-income patients. The incident also underscored the company’s extensive lobbying and political donation efforts aimed at influencing state healthcare policies.

Centene Corporation agreed to a $215 million settlement with California over allegations of overcharging the state for pharmacy services under Medicaid. This settlement highlights concerns regarding unethical business practices that undermine vulnerable public healthcare programs.

Centene Corporation agreed to pay over $215 million to California to settle accusations of overbilling its Medicaid program by inflating drug costs and fees. The settlement comes amid investigations by more than 20 states and follows claims that the company, while denying wrongdoing, benefitted from undisclosed discounts and engaged in extensive lobbying and political contributions aimed at influencing Medicaid contract decisions.

Centene has settled investigations into its Medicaid pharmacy billing practices in more than 20 states, paying a total of approximately $613 million. The most recent settlement was in Oregon on December 6, 2022, marking another instance of the company resolving accusations of overbilling taxpayers while continuing to pursue lucrative government contracts.

Between January 2015 and October 2022, Centene and its executives channeled over $26.9 million in political donations, including personal contributions by then-CEO Michael Neidorff and his wife. These donations were made strategically in states where Centene is pursuing Medicaid contracts and facing overbilling accusations, reflecting a deliberate effort to influence policymaking and secure lucrative government contracts.

Centene and its subsidiaries funneled over $26.9 million to political campaigns across 33 states, employing tactics such as channeling donations through multiple subsidiaries to bypass contribution limits and to secure lucrative Medicaid contracts. The practice, coupled with personal contributions by top executives, reinforces concerns of a pay-to-play system that undermines democratic governance.